![Channing Der heashot](https://unclineberger.org/wp-content/uploads/sites/867/2019/08/Channing-Der-Horizontal-600x400.jpg)
November 26, 2019
Der named AAAS Fellow
The honor recognizes Der's contributions to cancer research. His lab's recent findings on pancreatic cancer have led to clinical studies of a new treatment.
November 26, 2019
The honor recognizes Der's contributions to cancer research. His lab's recent findings on pancreatic cancer have led to clinical studies of a new treatment.
November 18, 2019
The KRAS gene is commonly mutated in cancer. In the journal Cancer Discovery, researchers led by Channing Der, PhD, and Aaron Hobbs, PhD, reported details of the role of the KRAS G12R mutation in pancreatic cancer, and therapeutic strategies that might work for this mutation type. By studying unique differences in DNA mutations within the same gene, researchers are working to uncover the mutation-specific mechanisms that drive cancerous growth.
March 4, 2019
Scientists at UNC Lineberger discovered a technique to make pancreatic cancer cells reliant on one energy source and then starve them of it, which has led to clinical studies of a novel treatment strategy.
April 13, 2018
UNC Lineberger researchers led by Channing Der, PhD, are reporting preclinical findings for a potential two-treatment strategy to block multiple mechanisms of cancer cell metabolism in pancreatic cancer at the American Association for Cancer Research Annual Meeting in Chicago.
May 9, 2016
In the lab of Channing Der, PhD, researchers believe they have found a promising strategy to target a type of pancreatic cancer that is notoriously resistant to treatment—pancreatic cancer that has a mutation in a gene called KRAS.
March 10, 2016
Kirsten Bryant, PhD, and Channing Der, PhD, shared personal stories of why they're driven to fight pancreatic cancer at the Pancreatic Cancer Action Network’s PurpleStride Leadership Breakfast in Durham, NC.
January 7, 2016
In the journal Cancer Cell, UNC Lineberger researchers report findings of a promising strategy to treat KRAS-mutant pancreatic cancers.
August 25, 2014
Kirsten Bryant, PhD, was recently recognized by the Pancreatic Cancer Action Network for her dual role in the fight against pancreatic cancer.
May 20, 2014
The 2014 Pancreatic Cancer Purple Stride 5K raised over $200,000 raised to support pancreatic cancer awareness and research. UNC Lineberger’s very own TEAM UNC and the Der Lab Team were the top two Purple Stride fundraising teams.